Michael Crossman Honigberg, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pre-Eclampsia | 14 | 2025 | 1261 | 4.440 |
Why?
|
Menopause, Premature | 7 | 2023 | 124 | 4.150 |
Why?
|
Hypertension, Pregnancy-Induced | 6 | 2025 | 532 | 2.840 |
Why?
|
Pregnancy Complications, Cardiovascular | 7 | 2025 | 521 | 2.560 |
Why?
|
Cardiovascular Diseases | 20 | 2025 | 15651 | 1.800 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 3 | 2024 | 561 | 1.550 |
Why?
|
Heart Failure | 18 | 2024 | 11840 | 1.340 |
Why?
|
Lipoprotein(a) | 4 | 2024 | 488 | 1.290 |
Why?
|
Peripartum Period | 5 | 2024 | 140 | 1.260 |
Why?
|
Coronary Artery Disease | 13 | 2025 | 6546 | 1.170 |
Why?
|
Eclampsia | 2 | 2023 | 61 | 1.000 |
Why?
|
Hypertension | 10 | 2025 | 8626 | 0.990 |
Why?
|
Pericarditis | 2 | 2024 | 137 | 0.980 |
Why?
|
Pregnancy | 29 | 2025 | 30258 | 0.940 |
Why?
|
Parity | 2 | 2025 | 931 | 0.900 |
Why?
|
Cardiomyopathies | 6 | 2024 | 2067 | 0.870 |
Why?
|
Puerperal Disorders | 3 | 2022 | 305 | 0.830 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2022 | 3251 | 0.800 |
Why?
|
Birth Weight | 4 | 2024 | 2122 | 0.740 |
Why?
|
Menopause | 5 | 2023 | 1659 | 0.730 |
Why?
|
Vascular Resistance | 1 | 2024 | 941 | 0.720 |
Why?
|
Microcirculation | 2 | 2024 | 1280 | 0.710 |
Why?
|
Pregnancy Trimester, First | 1 | 2025 | 920 | 0.700 |
Why?
|
Atherosclerosis | 5 | 2024 | 3425 | 0.700 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2024 | 12240 | 0.680 |
Why?
|
Prediabetic State | 2 | 2022 | 548 | 0.640 |
Why?
|
Pregnancy Outcome | 4 | 2023 | 2967 | 0.640 |
Why?
|
Gestational Age | 3 | 2024 | 3613 | 0.620 |
Why?
|
Dioxygenases | 4 | 2024 | 354 | 0.620 |
Why?
|
Penicillin G Benzathine | 1 | 2018 | 24 | 0.620 |
Why?
|
Postmenopause | 4 | 2023 | 2515 | 0.620 |
Why?
|
Risk Factors | 34 | 2025 | 74836 | 0.610 |
Why?
|
Female | 72 | 2025 | 396101 | 0.610 |
Why?
|
Coronary Circulation | 1 | 2024 | 1602 | 0.580 |
Why?
|
Atrial Fibrillation | 4 | 2024 | 5189 | 0.580 |
Why?
|
Reproduction | 1 | 2022 | 641 | 0.560 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 242 | 0.560 |
Why?
|
Stroke Volume | 8 | 2024 | 5596 | 0.560 |
Why?
|
Gonadal Steroid Hormones | 1 | 2021 | 705 | 0.540 |
Why?
|
Ventricular Remodeling | 2 | 2024 | 1272 | 0.540 |
Why?
|
Mendelian Randomization Analysis | 6 | 2024 | 1044 | 0.540 |
Why?
|
Humans | 94 | 2025 | 765956 | 0.540 |
Why?
|
Anticholesteremic Agents | 2 | 2024 | 970 | 0.500 |
Why?
|
Syphilis | 1 | 2018 | 243 | 0.500 |
Why?
|
Primary Prevention | 2 | 2021 | 1187 | 0.490 |
Why?
|
Proteome | 2 | 2024 | 1899 | 0.480 |
Why?
|
Adult | 34 | 2025 | 223038 | 0.480 |
Why?
|
Pregnancy Trimester, Second | 1 | 2018 | 738 | 0.480 |
Why?
|
Hypercholesterolemia | 1 | 2022 | 1149 | 0.470 |
Why?
|
Pregnancy Trimesters | 1 | 2015 | 198 | 0.460 |
Why?
|
Antirheumatic Agents | 1 | 2024 | 1365 | 0.450 |
Why?
|
Coronary Angiography | 3 | 2025 | 4494 | 0.450 |
Why?
|
Heart Arrest | 1 | 2024 | 1516 | 0.440 |
Why?
|
Coronary Aneurysm | 1 | 2016 | 233 | 0.440 |
Why?
|
Hypertension, Pulmonary | 2 | 2022 | 1604 | 0.430 |
Why?
|
Vascular Diseases | 1 | 2022 | 1159 | 0.430 |
Why?
|
Women's Health | 5 | 2025 | 2084 | 0.420 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5891 | 0.420 |
Why?
|
Genome-Wide Association Study | 9 | 2024 | 12807 | 0.410 |
Why?
|
Heart Rate | 3 | 2023 | 4203 | 0.390 |
Why?
|
Meningitis | 1 | 2013 | 216 | 0.390 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9524 | 0.380 |
Why?
|
Hematopoiesis | 5 | 2023 | 2058 | 0.380 |
Why?
|
Action Potentials | 1 | 2019 | 1838 | 0.370 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2016 | 537 | 0.370 |
Why?
|
Myocardial Ischemia | 1 | 2021 | 2128 | 0.340 |
Why?
|
Kidney Diseases | 1 | 2021 | 2098 | 0.340 |
Why?
|
Biological Specimen Banks | 5 | 2022 | 786 | 0.340 |
Why?
|
Melanocytes | 1 | 2013 | 515 | 0.340 |
Why?
|
Mosaicism | 2 | 2024 | 481 | 0.340 |
Why?
|
Blood Glucose | 2 | 2022 | 6425 | 0.340 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2024 | 3446 | 0.330 |
Why?
|
Premature Birth | 1 | 2022 | 1829 | 0.330 |
Why?
|
Health Services Accessibility | 2 | 2025 | 5506 | 0.330 |
Why?
|
Chest Pain | 1 | 2016 | 1100 | 0.320 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2015 | 845 | 0.310 |
Why?
|
Blood Pressure | 6 | 2025 | 8532 | 0.310 |
Why?
|
Microvessels | 2 | 2024 | 591 | 0.300 |
Why?
|
Middle Aged | 32 | 2025 | 223004 | 0.300 |
Why?
|
Electrocardiography | 2 | 2019 | 6404 | 0.300 |
Why?
|
Cholesterol, LDL | 3 | 2024 | 2393 | 0.300 |
Why?
|
Heart Ventricles | 1 | 2020 | 3832 | 0.300 |
Why?
|
Proto-Oncogene Proteins | 4 | 2024 | 4520 | 0.300 |
Why?
|
Hypoglycemic Agents | 1 | 2020 | 3110 | 0.290 |
Why?
|
Coronary Disease | 1 | 2022 | 5912 | 0.290 |
Why?
|
Postpartum Period | 2 | 2025 | 1203 | 0.280 |
Why?
|
Arrhythmias, Cardiac | 2 | 2022 | 2247 | 0.270 |
Why?
|
Risk Assessment | 5 | 2025 | 24283 | 0.260 |
Why?
|
Colchicine | 2 | 2024 | 256 | 0.260 |
Why?
|
Genetic Predisposition to Disease | 5 | 2025 | 18071 | 0.260 |
Why?
|
Male | 33 | 2025 | 363691 | 0.250 |
Why?
|
Thiazoles | 1 | 2013 | 1529 | 0.250 |
Why?
|
Hormone Replacement Therapy | 2 | 2022 | 753 | 0.240 |
Why?
|
Infant, Newborn | 6 | 2024 | 26349 | 0.240 |
Why?
|
Education, Medical | 1 | 2017 | 1746 | 0.240 |
Why?
|
Young Adult | 10 | 2025 | 59886 | 0.240 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2024 | 16047 | 0.230 |
Why?
|
Aged | 19 | 2025 | 171114 | 0.230 |
Why?
|
Meningeal Neoplasms | 1 | 2013 | 1252 | 0.230 |
Why?
|
Hyperglycemia | 1 | 2013 | 1393 | 0.230 |
Why?
|
Aminopeptidases | 1 | 2024 | 113 | 0.230 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2024 | 67 | 0.220 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3278 | 0.220 |
Why?
|
Hospitalization | 4 | 2022 | 10808 | 0.220 |
Why?
|
DNA-Binding Proteins | 4 | 2024 | 9601 | 0.210 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3925 | 0.210 |
Why?
|
Incidence | 7 | 2024 | 21480 | 0.200 |
Why?
|
Radon | 1 | 2024 | 90 | 0.200 |
Why?
|
Piperazines | 1 | 2013 | 2549 | 0.200 |
Why?
|
Bradycardia | 1 | 2024 | 302 | 0.200 |
Why?
|
Repressor Proteins | 2 | 2024 | 2968 | 0.190 |
Why?
|
Chromosomes, Human, Y | 1 | 2022 | 163 | 0.190 |
Why?
|
Coronary Vessels | 2 | 2024 | 3097 | 0.190 |
Why?
|
Disease Management | 2 | 2022 | 2535 | 0.180 |
Why?
|
Stroke | 4 | 2024 | 9747 | 0.180 |
Why?
|
Sex Characteristics | 2 | 2022 | 2643 | 0.180 |
Why?
|
Chromosome Aberrations | 2 | 2024 | 1774 | 0.170 |
Why?
|
Hematologic Neoplasms | 2 | 2023 | 1927 | 0.170 |
Why?
|
Receptors, Interleukin-6 | 1 | 2022 | 226 | 0.170 |
Why?
|
Interleukin-1 | 1 | 2024 | 1243 | 0.170 |
Why?
|
Prospective Studies | 7 | 2025 | 54806 | 0.170 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2024 | 345 | 0.170 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7478 | 0.160 |
Why?
|
Antipsychotic Agents | 1 | 2013 | 3074 | 0.160 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 7875 | 0.160 |
Why?
|
Myocardial Infarction | 4 | 2024 | 11501 | 0.160 |
Why?
|
Dicarboxylic Acids | 1 | 2019 | 75 | 0.160 |
Why?
|
Cohort Studies | 8 | 2024 | 41647 | 0.160 |
Why?
|
Norway | 1 | 2020 | 499 | 0.160 |
Why?
|
Chromosomes, Human, X | 1 | 2021 | 319 | 0.160 |
Why?
|
Physicians | 1 | 2017 | 4588 | 0.160 |
Why?
|
Time Factors | 4 | 2024 | 40065 | 0.160 |
Why?
|
Mutation | 7 | 2024 | 30196 | 0.150 |
Why?
|
Prognosis | 4 | 2022 | 29921 | 0.150 |
Why?
|
Sex Factors | 2 | 2022 | 10602 | 0.150 |
Why?
|
Quality of Life | 1 | 2020 | 13461 | 0.150 |
Why?
|
United States | 10 | 2024 | 72898 | 0.150 |
Why?
|
Hematopoietic Stem Cells | 4 | 2024 | 3401 | 0.150 |
Why?
|
Janus Kinase 2 | 1 | 2021 | 562 | 0.150 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2022 | 389 | 0.140 |
Why?
|
Chronic Disease | 3 | 2019 | 9347 | 0.140 |
Why?
|
Neovascularization, Physiologic | 1 | 2024 | 1375 | 0.140 |
Why?
|
Directive Counseling | 1 | 2019 | 171 | 0.140 |
Why?
|
Aspirin | 3 | 2024 | 3134 | 0.140 |
Why?
|
Ovariectomy | 1 | 2019 | 611 | 0.140 |
Why?
|
Placenta | 2 | 2024 | 1728 | 0.140 |
Why?
|
Telomere | 1 | 2023 | 943 | 0.140 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2022 | 2310 | 0.140 |
Why?
|
Dyslipidemias | 1 | 2024 | 869 | 0.130 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2024 | 953 | 0.130 |
Why?
|
Multifactorial Inheritance | 1 | 2024 | 1425 | 0.130 |
Why?
|
Doxycycline | 1 | 2018 | 349 | 0.130 |
Why?
|
Asymptomatic Diseases | 1 | 2019 | 586 | 0.130 |
Why?
|
T-Lymphocyte Subsets | 1 | 2024 | 1811 | 0.130 |
Why?
|
Incidental Findings | 1 | 2021 | 697 | 0.130 |
Why?
|
Contact Tracing | 1 | 2018 | 274 | 0.130 |
Why?
|
Sex Distribution | 1 | 2021 | 2263 | 0.130 |
Why?
|
Pulmonary Artery | 1 | 2024 | 1935 | 0.120 |
Why?
|
North America | 1 | 2019 | 1285 | 0.120 |
Why?
|
Organ Size | 1 | 2020 | 2261 | 0.120 |
Why?
|
Secondary Prevention | 1 | 2021 | 1472 | 0.120 |
Why?
|
Leukocytes | 1 | 2023 | 2027 | 0.120 |
Why?
|
Recurrence | 2 | 2024 | 8501 | 0.120 |
Why?
|
Age Distribution | 1 | 2021 | 2858 | 0.120 |
Why?
|
Infant, Small for Gestational Age | 1 | 2018 | 469 | 0.120 |
Why?
|
Predictive Value of Tests | 3 | 2024 | 15398 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2022 | 1789 | 0.120 |
Why?
|
Breast Feeding | 1 | 2023 | 1363 | 0.120 |
Why?
|
Severity of Illness Index | 2 | 2024 | 15880 | 0.120 |
Why?
|
Hyperlipidemias | 1 | 2019 | 770 | 0.120 |
Why?
|
Neoplasms | 2 | 2024 | 22340 | 0.120 |
Why?
|
Exercise Tolerance | 1 | 2020 | 841 | 0.120 |
Why?
|
Heart Diseases | 2 | 2024 | 2821 | 0.110 |
Why?
|
Lipids | 2 | 2024 | 3316 | 0.110 |
Why?
|
Life Style | 2 | 2023 | 3926 | 0.110 |
Why?
|
Neck | 1 | 2018 | 733 | 0.110 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2020 | 1094 | 0.100 |
Why?
|
Organizational Innovation | 1 | 2016 | 541 | 0.100 |
Why?
|
Diabetes, Gestational | 1 | 2022 | 1264 | 0.100 |
Why?
|
Brain Neoplasms | 1 | 2013 | 9071 | 0.100 |
Why?
|
Proportional Hazards Models | 3 | 2024 | 12509 | 0.100 |
Why?
|
Healthcare Disparities | 2 | 2025 | 3412 | 0.100 |
Why?
|
Endothelial Cells | 1 | 2024 | 3584 | 0.100 |
Why?
|
Fatty Acids | 1 | 2019 | 1806 | 0.100 |
Why?
|
Guideline Adherence | 1 | 2022 | 2243 | 0.090 |
Why?
|
Proteomics | 1 | 2024 | 3910 | 0.090 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 12976 | 0.090 |
Why?
|
Health Surveys | 1 | 2021 | 4056 | 0.090 |
Why?
|
Retina | 1 | 2021 | 2657 | 0.090 |
Why?
|
Brain Ischemia | 1 | 2024 | 3000 | 0.090 |
Why?
|
Ventricular Function, Left | 2 | 2024 | 3928 | 0.090 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2021 | 2136 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1946 | 0.090 |
Why?
|
Thrombosis | 1 | 2024 | 2949 | 0.080 |
Why?
|
Antihypertensive Agents | 3 | 2025 | 2033 | 0.080 |
Why?
|
Hyperlipoproteinemia Type II | 2 | 2025 | 394 | 0.080 |
Why?
|
Patient Acceptance of Health Care | 1 | 2023 | 3229 | 0.080 |
Why?
|
Genomics | 2 | 2025 | 5929 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1882 | 0.080 |
Why?
|
Macrophages | 1 | 2024 | 5772 | 0.080 |
Why?
|
Overweight | 1 | 2020 | 2443 | 0.080 |
Why?
|
Cells, Cultured | 1 | 2024 | 18973 | 0.080 |
Why?
|
Heart | 1 | 2022 | 4414 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2016 | 1509 | 0.080 |
Why?
|
Pneumonia | 1 | 2020 | 2157 | 0.080 |
Why?
|
Fatal Outcome | 1 | 2013 | 1831 | 0.080 |
Why?
|
Recovery of Function | 1 | 2019 | 2966 | 0.080 |
Why?
|
Mental Health | 1 | 2023 | 3272 | 0.080 |
Why?
|
Risk | 1 | 2020 | 9591 | 0.080 |
Why?
|
Linear Models | 1 | 2018 | 5876 | 0.070 |
Why?
|
Faculty, Medical | 1 | 2016 | 1219 | 0.070 |
Why?
|
Patient Selection | 1 | 2020 | 4255 | 0.070 |
Why?
|
C-Reactive Protein | 3 | 2024 | 3850 | 0.070 |
Why?
|
ROC Curve | 1 | 2015 | 3620 | 0.070 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6547 | 0.070 |
Why?
|
Age Factors | 1 | 2024 | 18380 | 0.070 |
Why?
|
Obesity | 4 | 2023 | 13075 | 0.070 |
Why?
|
Education, Medical, Undergraduate | 1 | 2016 | 1085 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3247 | 0.070 |
Why?
|
Death, Sudden, Cardiac | 1 | 2015 | 1568 | 0.070 |
Why?
|
Comorbidity | 1 | 2020 | 10563 | 0.060 |
Why?
|
Registries | 1 | 2022 | 8297 | 0.060 |
Why?
|
Defibrillators, Implantable | 1 | 2015 | 1490 | 0.060 |
Why?
|
HIV Infections | 2 | 2024 | 17533 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2022 | 7425 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12057 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2024 | 6942 | 0.060 |
Why?
|
Adolescent | 2 | 2023 | 88832 | 0.060 |
Why?
|
Apolipoprotein B-100 | 1 | 2024 | 157 | 0.050 |
Why?
|
Curriculum | 1 | 2017 | 3782 | 0.050 |
Why?
|
Adrenomedullin | 1 | 2023 | 85 | 0.050 |
Why?
|
Depression | 1 | 2023 | 8230 | 0.050 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2024 | 173 | 0.050 |
Why?
|
Students, Medical | 1 | 2016 | 1959 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39194 | 0.050 |
Why?
|
Postnatal Care | 1 | 2025 | 274 | 0.050 |
Why?
|
Apolipoprotein A-I | 1 | 2023 | 304 | 0.050 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2024 | 335 | 0.050 |
Why?
|
Animals | 6 | 2024 | 168759 | 0.050 |
Why?
|
Signal Transduction | 1 | 2024 | 23600 | 0.050 |
Why?
|
Logistic Models | 1 | 2015 | 13266 | 0.040 |
Why?
|
Inpatients | 2 | 2022 | 2564 | 0.040 |
Why?
|
Blood Cell Count | 1 | 2021 | 405 | 0.040 |
Why?
|
Platelet Activation | 1 | 2024 | 645 | 0.040 |
Why?
|
Subcutaneous Tissue | 1 | 2021 | 130 | 0.040 |
Why?
|
Mice | 5 | 2024 | 81818 | 0.040 |
Why?
|
Primary Health Care | 1 | 2016 | 4736 | 0.040 |
Why?
|
Health Status | 2 | 2023 | 4080 | 0.040 |
Why?
|
Blood Proteins | 1 | 2024 | 1188 | 0.040 |
Why?
|
Arteries | 1 | 2024 | 1118 | 0.040 |
Why?
|
Troponin T | 1 | 2024 | 785 | 0.040 |
Why?
|
Psychotic Disorders | 1 | 2013 | 3268 | 0.040 |
Why?
|
Eye Proteins | 1 | 2021 | 628 | 0.040 |
Why?
|
Age of Onset | 1 | 2024 | 3343 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2023 | 65189 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2023 | 1811 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2024 | 21056 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14749 | 0.030 |
Why?
|
Demography | 1 | 2021 | 1641 | 0.030 |
Why?
|
Phenotype | 2 | 2024 | 16721 | 0.030 |
Why?
|
Triglycerides | 1 | 2023 | 2441 | 0.030 |
Why?
|
Child | 1 | 2023 | 80563 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2022 | 1741 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2024 | 3222 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2023 | 2268 | 0.030 |
Why?
|
Blood Platelets | 1 | 2024 | 2464 | 0.030 |
Why?
|
Aortic Valve Stenosis | 1 | 2024 | 2023 | 0.020 |
Why?
|
Self Report | 1 | 2023 | 3771 | 0.020 |
Why?
|
Genetic Loci | 1 | 2021 | 2631 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2741 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 26313 | 0.020 |
Why?
|
Echocardiography | 1 | 2024 | 5045 | 0.020 |
Why?
|
Odds Ratio | 1 | 2022 | 9649 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2024 | 14447 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4392 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4424 | 0.020 |
Why?
|
Genotype | 1 | 2021 | 13024 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2016 | 1458 | 0.020 |
Why?
|
Aging | 1 | 2024 | 8731 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18294 | 0.020 |
Why?
|
Smoking | 1 | 2022 | 9081 | 0.010 |
Why?
|
Patient Care Team | 1 | 2016 | 2517 | 0.010 |
Why?
|
Transcription Factors | 1 | 2024 | 12131 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10850 | 0.010 |
Why?
|
Massachusetts | 1 | 2016 | 8871 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 11888 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2024 | 13451 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20660 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2025 | 81515 | 0.010 |
Why?
|